Source: Science Daily
“ScienceDaily (Oct. 15, 2009) — A team of researchers at the MUHC/McGill and their international colleagues recommend halting all clinical trials on interleukin-2.
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped. Their finding was published in the New England Journal of Medicine in an article co-authored by 14 researchers, including Dr. Jean-Pierre Routy of the Research Institute of the McGill University Health Centre (RI-MUHC).”
Click here to read more.